WASHINGTON—With the number of veterans being diagnosed with hepatocellular carcinoma continuing to rise, the VA has implemented several new initiatives to improve outcomes for patients with this aggressive cancer. The most common type of liver... View Article
HOUSTON—A new epidemic appears poised to overtake hepatitis C as the leading cause of hepatocellular carcinoma. “Nonalcoholic fatty liver disease is the next big thing in the epidemiology of liver cancer,” said Fasiha Kanwal, MD,... View Article
HOUSTON—The VA has announced that it expects to eliminate hepatitis C in all veterans willing and able to receive treatment by May of this year. Successful treatment for HCV also dramatically reduces the risk of... View Article
RICHMOND, VA—For more than a decade after the U.S. Food and Drug Administration approved sorafenib for hepatocellular cancer, treatment options for the aggressive malignancy remained static. That changed dramatically in the last 24 months as... View Article
© 2000-2018. All Materials Copyright Marathon Medical Communications, Inc.